“…Agents that block the renin angiotensin system have shown glucoregulatory potential in the context of metabolic syndrome ( Jahandideh & Wu, 2020 ). The work from our group has shown the insulin sensitizing and mimetic properties of different food-derived antihypertensive peptides ( Chakrabarti et al, 2018 , Jahandideh et al, 2019 , Jahandideh et al, 2017 ). VPP and IPP, the casein-derived tripeptides with well-known antihypertensive properties ( Kim et al, 2008 , Nakamura et al, 2011 ) also enhanced insulin signaling and contributed toward the prevention of insulin resistance in the presence of tumor necrosis factor in 3T3-F442A adipocytes (Chakrabarti, Jahandideh, Liu, & Wu, 2018 ).…”